Seeking Alpha

Sucampo Pharmaceuticals (SCMP) -8.4% premarket after announcing Friday the FDA extended by three...

Sucampo Pharmaceuticals (SCMP) -8.4% premarket after announcing Friday the FDA extended by three months its review of the company's Amitiza drug to treat opioid-induced constipation in patients with chronic, non-cancer pain. The FDA decides to extend the goal date to provide time for a full review of supportive analyses it had requested.
Comments (1)
  • >>Wheeler Real Estate Investment Trust (WHLR) declares its first-ever quarterly dividend of $0.049/share.<<

     

    It's a monthly dividend, and this first one includes 12 days of November (post-IPO) as well as December so forward yield is ~7%. Management is planning on a $0.42 per year payout going forward or $0.035/month after this first, larger one.
    3 Dec 2012, 08:49 AM Reply Like
DJIA (DIA) S&P 500 (SPY)